Cashu | News | PAVM

HomeWatchlistNewsSignalsPicks

DJI

-0.51%

SPX

+0.06%

IXIC

+0.52%

FTSE

+0.67%

N225

-0.88%

AXJO

-1.82%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest PAVmed News

PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging Technology

Feature Image for interests on Health Care & Hospitals, Healthcare, Licensing, Medical Equipment from prnewswire.com

finance.yahoo.com

Lucid Diagnostics to Join Global Medtech Leaders at The MedTech Conference 2024

Feature Image for interests on Advamed, Canada, Esophageal Cancer, Healthcare from finance.yahoo.com

finance.yahoo.com

American Foregut Society's 2024 Annual Meeting to Highlight Lucid Diagnostics' EsoGuard Esophageal Precancer Test

Feature Image for interests on Afs, American Foregut Society, Annual Meeting, Cancer Prevention from finance.yahoo.com

finance.yahoo.com

Lucid Diagnostics to Host Symposium on Non-Endoscopic Esophageal Precancer Screening at the 20th International Society for Diseases of the Esophagus (ISDE) World Congress

Feature Image for interests on Cancer Prevention, Edinburgh International Convention Centre, Esophageal Disease, Esophageal Diseases from finance.yahoo.com

finance.yahoo.com

Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health

Feature Image for interests on Comprehensive Medical Care, Esophageal Cancer, Firefighters, Front Line from finance.yahoo.com

about 1 year ago

finance.yahoo.com

Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard for Early Detection of Esophageal Precancer and Cancer

Feature Image for interests on Cancer Prevention, Esoguard, Esophageal Adenocarcinoma, Healthcare from finance.yahoo.com

about 1 year ago

finance.yahoo.com

PAVmed Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Feature Image for interests on Earnings Per Share, Healthcare, Revenue Growth, Stock from finance.yahoo.com

about 1 year ago

finance.yahoo.com

Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial Results

Feature Image for interests on Clinical Data, Esophageal Cancer, Financial Measures, Financial Results from finance.yahoo.com

about 1 year ago

finance.yahoo.com

Lucid Diagnostics Holds First Major Directly-Contracted EsoGuard #CheckYourFoodTube Precancer Testing Event

Feature Image for interests on Cancer Prevention, Esophageal Cancer, Fort Worth Fire Department, Front Line from finance.yahoo.com

about 1 year ago

finance.yahoo.com

Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard Esophageal Precancer Testing

Feature Image for interests on Cancer Prevention, Esophageal Cancer, Healthcare, Lucid from finance.yahoo.com

about 1 year ago

Stocks

Health Care

pavm

PAVmed

NASDAQ: PAVM

+0.01 (+1.24%)

0.4478

USD

At close at Sep 03, 18:40 UTC

Latest Cashu News

PAVmed Collaborates with Duke University to Enhance Esophageal Dysplasia Diagnosis Technology

PAVmed Partners with Duke University to Innovate Esophageal Dysplasia Diagnosis Technology

PAVmed Partners with Duke University to Innovate Esophageal Cancer Diagnostics